Literature DB >> 23991623

P2Y12 inhibition in patients with NSTEMI--can later be better?

John F Keaney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23991623      PMCID： PMC3872834          DOI： 10.1056/NEJMe1308820

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).

Authors:  Christian W Hamm; Jean-Pierre Bassand; Stefan Agewall; Jeroen Bax; Eric Boersma; Hector Bueno; Pio Caso; Dariusz Dudek; Stephan Gielen; Kurt Huber; Magnus Ohman; Mark C Petrie; Frank Sonntag; Miguel Sousa Uva; Robert F Storey; William Wijns; Doron Zahger
Journal:  Eur Heart J       Date:  2011-08-26       Impact factor: 29.983

2.  2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Hani Jneid; Jeffrey L Anderson; R Scott Wright; Cynthia D Adams; Charles R Bridges; Donald E Casey; Steven M Ettinger; Francis M Fesmire; Theodore G Ganiats; A Michael Lincoff; Eric D Peterson; George J Philippides; Pierre Theroux; Nanette K Wenger; James Patrick Zidar
Journal:  J Am Coll Cardiol       Date:  2012-07-16       Impact factor: 24.094

3.  Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.

Authors:  S R Mehta; S Yusuf; R J Peters; M E Bertrand; B S Lewis; M K Natarajan; K Malmberg; H Rupprecht; F Zhao; S Chrolavicius; I Copland; K A Fox
Journal:  Lancet       Date:  2001-08-18       Impact factor: 79.321

4.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

Authors:  S Yusuf; F Zhao; S R Mehta; S Chrolavicius; G Tognoni; K K Fox
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

5.  Prasugrel versus clopidogrel in patients with acute coronary syndromes.

Authors:  Stephen D Wiviott; Eugene Braunwald; Carolyn H McCabe; Gilles Montalescot; Witold Ruzyllo; Shmuel Gottlieb; Franz-Joseph Neumann; Diego Ardissino; Stefano De Servi; Sabina A Murphy; Jeffrey Riesmeyer; Govinda Weerakkody; C Michael Gibson; Elliott M Antman
Journal:  N Engl J Med       Date:  2007-11-04       Impact factor: 91.245

6.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

Authors:  Lars Wallentin; Richard C Becker; Andrzej Budaj; Christopher P Cannon; Håkan Emanuelsson; Claes Held; Jay Horrow; Steen Husted; Stefan James; Hugo Katus; Kenneth W Mahaffey; Benjamin M Scirica; Allan Skene; Philippe Gabriel Steg; Robert F Storey; Robert A Harrington; Anneli Freij; Mona Thorsén
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

7.  Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention.

Authors:  Steven R Steinhubl; Peter B Berger; Danielle M Brennan; Eric J Topol
Journal:  J Am Coll Cardiol       Date:  2006-02-09       Impact factor: 24.094

8.  Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial.

Authors:  Alan D Michelson; Andrew L Frelinger; Eugene Braunwald; William E Downey; Dominick J Angiolillo; Nicholas P Xenopoulos; Joseph A Jakubowski; Youfu Li; Sabina A Murphy; Jie Qin; Carolyn H McCabe; Elliott M Antman; Stephen D Wiviott
Journal:  Eur Heart J       Date:  2009-05-12       Impact factor: 29.983

9.  Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.

Authors:  Ramin Ebrahimi; Cornelius Dyke; Roxana Mehran; Steven V Manoukian; Frederick Feit; David A Cox; Bernard J Gersh; E Magnus Ohman; Harvey D White; Jeffrey W Moses; James H Ware; A Michael Lincoff; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2009-05-26       Impact factor: 24.094
  9 in total
  1 in total

Review 1.  When is the Best Time for the Second Antiplatelet Agent in Non-St Elevation Acute Coronary Syndrome?

Authors:  Pedro Gabriel Melo de Barros e Silva; Henrique Barbosa Ribeiro; Antônio Claudio do Amaral Baruzzi; Expedito Eustáquio Ribeiro da Silva
Journal:  Arq Bras Cardiol       Date:  2016-03       Impact factor: 2.000
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.